GIK is a pharmacologic regimen that has been extensively studied as adjunctive therapy in STEMI patients to reduce reperfusion injury. The majority of recent trials do not demonstrate a benefit on clinical outcomes.
Glucose-insulin-potassium infusion
Insulin shock therapy
Hemodialysis
Peritoneal dialysis
Dialysis
Iridodialysis
Intensive insulinotherapy
Hemofiltration